Assessment of the Na/I symporter as a reporter gene to visualize oncolytic adenovirus propagation in peritoneal tumours

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 7, 2010, Pages 1377-1385

  Merron, Andrew ^a   Baril, Patrick ^b,c   Martin Duque, Pilar ^d   De La Vieja, Antonio ^e   Tran, Lucile ^b,c   Briat, Arnaud ^f   Harrington, Kevin J ^g   McNeish, Iain A ^a   Vassaux, Georges ^b,c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b HÔTEL DIEU   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

^d FUNDACIÓN ARAID   (Spain)

^e INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^f INSERM   (France)

^g INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Gene therapy; Molecular imaging; Na I symporter; Oncolytic adenovirus; SPECT CT

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOVIRUS VECTOR; ONCOLYTIC ADENOVIRUS; SODIUM IODINE SYMPORTER; UNCLASSIFIED DRUG; COTRANSPORTER; ONCOLYTIC VIRUS; SODIUM IODIDE SYMPORTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CELL KILLING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; GENE INSERTION; GENETIC CODE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OVARY CARCINOMA; PERITONEAL CAVITY; PERITONEAL OVARIAN CARCINOMA; PERITONEUM CANCER; REPORTER GENE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THERAPY EFFECT; VIRAL GENE THERAPY; VIRUS GENOME; VIRUS INFECTION; VIRUS REPLICATION; ADENOVIRIDAE; ANIMAL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; INTRAPERITONEAL DRUG ADMINISTRATION; MOLECULAR IMAGING; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; PHYSIOLOGY; PROCEDURES; TUMOR CELL LINE; VIROLOGY;

ADENOVIRIDAE; ANIMALS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; GENOME, VIRAL; INJECTIONS, INTRAPERITONEAL; MICE; MOLECULAR IMAGING; ONCOLYTIC VIRUSES; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; SYMPORTERS; VIRUS REPLICATION;

EID: 77954959571     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1379-3     Document Type: Article

References (46)

1. Baril P, Martin-Duque P, Vassaux G. Visualization of gene expression in the live subject using the Na/I symporter as a reporter gene: applications in biotherapy. Br J Pharmacol 2009. doi:10.1111/j.1476-5381.2009.00412.x.
2. Dadachova E, Carrasco N. The Na/I symporter (NIS): imaging and therapeutic applications. Semin Nucl Med 2004;34:23-31.
3. Vassaux G, Groot-Wassink T. In vivo noninvasive imaging for gene therapy. J Biomed Biotechnol 2003;2003:92-101.
4. Serganova I, Ponomarev V, Blasberg R. Human reporter genes: potential use in clinical studies. Nucl Med Biol 2007;34:791-807.
5. Faivre J, Clerc J, Gerolami R, et al. Long-term radioiodine retention and regression of liver cancer after sodium iodide symporter gene transfer in wistar rats. Cancer Res 2004;64:8045-51.
6. Marsee DK, Shen DH, MacDonald LR, et al. Imaging of metastatic pulmonary tumors following NIS gene transfer using single photon emission computed tomography. Cancer Gene Ther 2004;11:121-7.
7. Shah K, Jacobs A, Breakefield XO, Weissleder R. Molecular imaging of gene therapy for cancer. Gene Ther 2004;11:1175-87.
8. Dohan O, Carrasco N. Advances in Na (+)/I (-) symporter (NIS) research in the thyroid and beyond. Mol Cell Endocrinol 2003;213:59-70.
9. Merron A, Peerlinck I, Martin-Duque P, et al. SPECT/CT imaging of oncolytic adenovirus propagation in tumours in vivo using the Na/I symporter as a reporter gene. Gene Ther 2007;14:1731-8.
10. Groot-Wassink T, Aboagye EO, Glaser M, Lemoine NR, Vassaux G. Adenovirus biodistribution and noninvasive imaging of gene expression in vivo by positron emission tomography using human sodium/iodide symporter as reporter gene. Hum Gene Ther 2002;13:1723-35.
11. Groot-Wassink T, Aboagye EO, Wang Y, Lemoine NR, Keith WN, Vassaux G. Noninvasive imaging of the transcriptional activities of human telomerase promoter fragments in mice. Cancer Res 2004;64:4906-11.
12. Groot-Wassink T, Aboagye EO, Wang Y, Lemoine NR, Reader AJ, Vassaux G. Quantitative imaging of Na/I symporter transgene expression using positron emission tomography in the living animal. Mol Ther 2004;9:436-42.
13. Chisholm EJ, Vassaux G, Martin-Duque P, et al. Cancer-specific transgene expression mediated by systemic injection of nano-particles. Cancer Res 2009;69:2655-62.
14. Kim HJ, Jeon YH, Kang JH, et al. In vivo long-term imaging and radioiodine therapy by sodium-iodide symporter gene expression using a lentiviral system containing ubiquitin C promoter. Cancer Biol Ther 2007;6:1130-5.
15. Kim KI, Chung JK, Kang JH, et al. Visualization of endogenous p53-mediated transcription in vivo using sodium iodide sym-porter. Clin Cancer Res 2005;11:123-8.
16. Yeom CJ, Chung JK, Kang JH, et al. Visualization of hypoxia-inducible factor-1 transcriptional activation in C6 glioma using luciferase and sodium iodide symporter genes. J Nucl Med 2008;49:1489-97.
17. Che J, Doubrovin M, Serganova I, et al. HSP70-inducible hNIS-IRES-eGFP reporter imaging: response to heat shock. Mol Imaging 2007;6:404-16.
18. Kim KI, Kang JH, Chung JK, et al. Doxorubicin enhances the expression of transgene under control of the CMV promoter in anaplastic thyroid carcinoma cells. J Nucl Med 2007;48:1553-61.
19. Chen L, Altman A, Mier W, Lu H, Zhu R, Haberkorn U. 99mTc-pertechnetate uptake in hepatoma cells due to tissue-specific human sodium iodide symporter gene expression. Nucl Med Biol 2006;33:575-80.
20. Hwang DW, Jang SJ, Kim YH, et al. Real-time in vivo monitoring of viable stem cells implanted on biocompatible scaffolds. Eur J Nucl Med Mol Imaging 2008;35:1887-98.
21. Lee KH, Bae JS, Lee SC, et al. Evidence that myocardial Na/I symporter gene imaging does not perturb cardiac function. J Nucl Med 2006;47:1851-7.
22. Boland A, Ricard M, Opolon P, et al. Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy. Cancer Res 2000;60:3484-92.
23. Montiel-Equihua CA, Martin-Duque P, de la Vieja A, et al. Targeting sodium/iodide symporter gene expression for estrogen-regulated imaging and therapy in breast cancer. Cancer Gene Ther 2008;15:465-73.
24. Goel A, Carlson SK, Classic KL, et al. Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV (Delta51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene. Blood 2007;110:2342-50.
25. Peerlinck I, Merron A, Baril P, et al. Targeted radionuclide therapy using a Wnt-targeted replicating adenovirus encoding the Na/I symporter. Clin Cancer Res 2009;15:6595-601.
26. Barton KN, Stricker H, Brown SL, et al. Phase I study of noninvasive imaging of adenovirus-mediated gene expression in the human prostate. Mol Ther 2008;16:1761-9.
27. Kaplan JM. Adenovirus-based cancer gene therapy. Curr Gene Ther. 2005;5:595-605.
28. Woo Y, Adusumilli PS, Fong Y. Advances in oncolytic viral therapy. Curr Opin Investig Drugs 2006;7:549-59.
29. Fueyo J, Gomez-Manzano C, Alemany R, et al. A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo. Oncogene 2000;19:2-12.
30. Gomez-Manzano C, Alonso MM, Yung WK, et al. Delta-24 increases the expression and activity of topoisomerase I and enhances the antiglioma effect of irinotecan. Clin Cancer Res 2006;12:556-62.
31. Lockley M, Fernandez M, Wang Y, et al. Activity of the adenoviral E1A deletion mutant dl922-947 in ovarian cancer: comparison with E1A wild-type viruses, bioluminescence moni-toring, and intraperitoneal delivery in icodextrin. Cancer Res 2006;66:989-98.
32. Dingli D, Peng KW, Harvey ME, et al. Image-guided radio-virotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter. Blood 2004;103:1641-6.
33. Peerlinck I, Amini-Nik S, Phillips RK, et al. Therapeutic potential of replication-selective oncolytic adenoviruses on cells from familial and sporadic desmoid tumors. Clin Cancer Res 2008;14:6187-92.
34. Gagnebin J, Brunori M, Otter M, Juillerat-Jeanneret L, Monnier P, Iggo R. A photosensitising adenovirus for photodynamic therapy. Gene Ther 1999;6:1742-50.
35. Vassaux G, Manson AL, Huxley C. Copy number-dependent expression of a YAC-cloned human CFTR gene in a human epithelial cell line. Gene Ther 1997;4:618-23. (Pubitemid 27352960)
36. Coughlan L, Vallath S, Saha A, et al. In vivo retargeting of adenovirus type 5 to alphavbeta6 integrin results in reduced hepatotoxicity and improved tumor uptake following systemic delivery. J Virol 2009;83:6416-28.
37. Martin-Duque P, Jezzard S, Kaftansis L, Vassaux G. Direct comparison of the insulating properties of two genetic elements in an adenoviral vector containing two different expression cassettes. Hum Gene Ther 2004;15:995-1002.
38. Hingorani M, White CL, Merron A, et al. Inhibition of repair of radiation-induced DNA damage enhances gene expression from replication-defective adenoviral vectors. Cancer Res 2008;68:9771-8.
39. Aoi A, Watanabe Y, Mori S, Takahashi M, Vassaux G, Kodama T. Herpes simplex virus thymidine kinase-mediated suicide gene therapy using nano/microbubbles and ultrasound. Ultrasound Med Biol 2008;34:425-34.
40. Briat A, Vassaux G. A new transgenic mouse line to image chemically induced p53 activation in vivo. Cancer Sci 2008;99:683-8.
41. Baird SK, Aerts JL, Eddaoudi A, Lockley M, Lemoine NR, McNeish IA. Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancer. Oncogene 2008;27:3081-90.
42. Johnson M, Huyn S, Burton J, Sato M, Wu L. Differential biodistribution of adenoviral vector in vivo as monitored by bioluminescence imaging and quantitative polymerase chain reaction. Hum Gene Ther 2006;17:1262-9.
43. Page JG, Tian B, Schweikart K, et al. Identifying the safety profile of a novel infectivity-enhanced conditionally replicative adenovi-rus, Ad5-delta24-RGD, in anticipation of a phase I trial for recurrent ovarian cancer. Am J Obstet Gynecol 2007;196:389 e1-9; discussion e9-10.
44. Bett AJ, Prevec L, Graham FL. Packaging capacity and stability of human adenovirus type 5 vectors. J Virol 1993;67:5911-21.
45. Parks RJ, Graham FL. A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging. J Virol 1997;71:3293-8.
46. Kennedy MA, Parks RJ. Adenovirus virion stability and the viral genome: size matters. Mol Ther 2009;17:1664-6.